Post Profile






Daiichi, Glaxo set up Japan venture

Japanese drugmaker Daiichi Sankyo and British peer GlaxoSmithKline are to form a 50-50 joint venture to bring new vaccines to Japan. ||| Japanese drugmaker Daiichi Sankyo and British peer GlaxoSmithKline are to form a 50-50 joint venture to bring new vaccines to Japan, targeting an underdeveloped segment of the world's second-biggest prescription drug market. News of the venture, which will likely create the top player in the Japanese vaccine market, sent shares of Japan's No.
read more

share

Related Posts


Daiichi Sankyo To Launch Percutaneous Analgesic And Anti-Inflammatory Drug Loxonin(R) Gel 1% In Japan

Health : Medical News Today

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced the launch in Japan of its percutaneous analgesic and anti-inflammatory drug Loxonin® Gel 1% (generic name, loxoprofen sodium hydrate; approval for manufacture an...

‘Glaxo used travel agencies for China bribes’

Business & Finance : Business Report

Chinese police accused British drugmaker GlaxoSmithKline of channelling bribes to Chinese officials and doctors. ||| Beijing - Chinese police on Monday accused British drugmaker GlaxoSmithKline of channelling bribes to Chinese offic...

GlaxoSmithKline to open global vaccine research center in Rockville

Technology : Washington Post: Tech

British drugmaker GlaxoSmithKline announced plans Thursday to open a new vaccine research center in Rockville this fall, a project that could bring up to 700 new jobs to Montgomery County. The center would combine two Glaxo research...

A.M. Vitals: Daiichi Sankyo, GlaxoSmithKline Form Vaccine Venture

Health : Wall Street Journal Health Blog

Also: CVS medication error; conflict over placenta; snoring and child behavior.

Japan's Daiichi Sankyo launches up to $3.6 billion stake sale in India's Sun Pharma

Business & Finance : Business Insider: Clusterstock

MUMBAI (Reuters) - Japan's Daiichi Sankyo Company Ltd is selling its stake worth up to $3.6 billion in Indian drugmaker Sun Pharmaceutical Industries Ltd, a person directly involved in the deal said on Monday. The Japanese company i...

Comments



Copyright © 2015 Regator, LLC